You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic granulocytic leukemia (CGL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CPI 613
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
May 10, 2023

Wellness, Psychological Trial in Guildford (A story based intervention called 'The Shadow of Tallystick Valley')

Not yet recruiting
  • Wellness, Psychological
  • A story based intervention called 'The Shadow of Tallystick Valley'
  • Guildford, Surrey, United Kingdom
    University of Surrey
Oct 12, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Nilotinib for Chronic Myeloid Leukemia in First Line and Any

    Completed
    • Chronic Myeloid Leukemia
    • Nilotinib
    • Freudenstadt, Baden Wuerttemberg, Germany
    • +76 more
    Feb 9, 2023

    Chronic Lymphocytic Leukemia Patients

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
      • San Francisco, California
        Power Life Sciences
      Jun 2, 2023

      Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

      Completed
      • Multiple Myeloma
      • Chronic Lymphocytic Leukemia
      • Myeloma Coach or CLL Coach Mobile App
      • Springboard Beyond Cancer informational website
      • Durham, North Carolina
        Duke University
      Jun 23, 2023

      Orelabrutinib in the Treatment of CLL/SLL

      Not yet recruiting
      • CLL/SLL
        • (no location specified)
        Jul 26, 2023

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +6 more
        • Miltenyi CliniMACS Prodigy ® system
        • (no location specified)
        Mar 23, 2023

        CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

        Not yet recruiting
        • CLL
        • (no location specified)
        Oct 3, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • (no location specified)
        Nov 22, 2023

        Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Loncastuximab Tesirine
        • (no location specified)
        Jul 24, 2023

        Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • (no location specified)
        Jul 10, 2023

        Understanding Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          Aug 1, 2022

          MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

          Recruiting
          • Myelodysplastic Syndromes
          • Chronic Myelomonocytic Leukemia
          • Tianjin, Tianjin, China
            Institute of Hematology & Blood Diseases Hospital, Chinese Acade
          Jul 30, 2023

          Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

          Not yet recruiting
          • Chronic Lymphocytic Leukemia
          • Small Lymphocytic Lymphoma
          • Pneumococcal 13-valent Conjugate Vaccine
          • Pneumococcal Polyvalent Vaccine
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Nov 10, 2022

          Systemic Lupus Erythematosus Trial in Vandoeuvre les nancy

          Not yet recruiting
          • Systemic Lupus Erythematosus
            • Vandoeuvre les nancy, Lorraine, France
              Thomas Moulinet
            Jun 15, 2022

            Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

            Recruiting
            • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • Biospecimen Collection
            • +4 more
            • Birmingham, Alabama
            • +170 more
            Jan 30, 2023

            Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

            Active, not recruiting
            • Acute Myeloid Leukemia
            • +9 more
            • Los Angeles, California
            • +5 more
            Jan 27, 2023

            Asciminib RMP Study

            Not yet recruiting
            • Chronic Myeloid Leukemia
            • Asciminib
            • (no location specified)
            Jul 5, 2023

            CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

            Recruiting
            • CML
            • +3 more
            • Asciminib add-on
            • +3 more
            • Augusta, Georgia
            • +46 more
            Jan 23, 2023

            Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

            Active, not recruiting
            • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • +6 more
            • Houston, Texas
              M D Anderson Cancer Center
            Dec 2, 2022